pillbase.ru

Blenrep

Active substance: belantamab mafodotin

INJECTION, POWDER, FOR SOLUTION · BELANTAMAB MAFODOTIN 50 mg/mL

United StatesActive

Marketing holder: GlaxoSmithKline LLC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Blenrep
    belantamab mafodotin
    EMEA/H/C/006511
    GlaxoSmithKline Trading Services Limited
  • Blenrep
    belantamab mafodotin
    EMEA/H/C/004935
    GlaxoSmithKline Trading Services Limited
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-44d5-758c-9d70-4c6ac71aafd1;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0173-0913
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 0173-0913 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0173-0913 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0173-0913 · Verified 2026-10-09 · open in source